Aggressive advanced soft tissue sarcoma case report – Myxofibrosarcoma (MFS) – had a long-term 48-month survival despite many negative clinical factors. It can be assumed that naturopathic therapy enhanced an antitumor cytotoxic effect of a conventional anticancer treatment (no lung metastasis during the period of 25 months) and also contributed to enhancing immune processes. It improved the patient’s quality of life and eventually prolonged his survival. It is believed that the above case is a unique example to demonstrate that integrative oncology care may have a modest, but significant effect on survival of a patient with surgically unresectable, metastatic soft tissue sarcoma. The primary challenge in managing the advanced MFS is the absence of effective systemic treatments. MFS frequently exhibits partial drug resistance or variable efficacy in response to standardized anticancer therapy. Therefore, complementary therapy may be considered as an option to improve therapeutic efficacy of conventional therapy.
https://karger.com/cro/article/19/1/458/944867/Integrative-Oncology-Approach-in-Advanced
Discuss what this means for you
Research can raise useful questions. A study or individual case report does not establish that a treatment is suitable for everyone. Discuss medications, supplements and treatment changes with your care team.
Talk with our team